Timing of antiretroviral therapy initiation and its impact on disease progression in perinatal human immunodeficiency virus-1 infection

Item

http://www.wikidata.org/entity/Q35655827

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Timing of antiretroviral thera ...... nodeficiency virus-1 infection

@ast

Timing of antiretroviral thera ...... nodeficiency virus-1 infection

@en

type

Item

label

Timing of antiretroviral thera ...... nodeficiency virus-1 infection

@ast

Timing of antiretroviral thera ...... nodeficiency virus-1 infection

@en

prefLabel

Timing of antiretroviral thera ...... nodeficiency virus-1 infection

@ast

Timing of antiretroviral thera ...... nodeficiency virus-1 infection

@en

P1476

Timing of antiretroviral thera ...... nodeficiency virus-1 infection

@en

P2093

Amy S Sturt

http://www.w3.org/2001/XMLSchema#string

Barbara Sullivan

http://www.w3.org/2001/XMLSchema#string

Meira S Halpern

http://www.w3.org/2001/XMLSchema#string

Yvonne A Maldonado

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008

Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy.

Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era

Early antiretroviral therapy and mortality among HIV-infected infants

Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland.

Causes of death in pediatric patients vertically infected by the human immunodeficiency virus type 1 in Madrid, Spain, from 1982 to mid-2009.

Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children.

Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms.

P304

53-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/INF.0B013E31823515A2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21979798

http://www.w3.org/2001/XMLSchema#string

P932

3252403

http://www.w3.org/2001/XMLSchema#string